Insomnia News and Research

Latest Insomnia News and Research

Good news for adults who suffer from insomnia

There's good news for the 30 per cent or more of adults who suffer from insomnia--difficulty falling asleep, waking up for prolonged periods during the night or unwanted early morning awakenings.

25 Jun 2014

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Alkermes plc today announced the presentation of data from its phase 3 clinical trial of aripiprazole lauroxil, an investigational drug candidate in development for schizophrenia, at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Fla.

18 Jun 2014

Researchers explore shiatsu to help people with chronic pain fall asleep

There was a time, back in Nancy Cheyne's youth, when she combined the poise and grace of a ballerina with the daring and grit of a barrel racer. When she wasn't pursuing either of those pastimes, she bred sheepdogs, often spending hours on her feet grooming her furry friends at dog shows.

18 Jun 2014

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.

17 Jun 2014

Fighting off illness causes sleep deprivation and affects memory

Sickness-induced insomnia is common because of link between brain and immune system. Fighting off illness- rather than the illness itself- causes sleep deprivation and affects memory, a new study has found.

13 Jun 2014

Proteins causing daytime sleepiness also play crucial role in bone formation

Orexin proteins, which are blamed for spontaneous daytime sleepiness, also play a crucial role in bone formation, according to findings by UT Southwestern Medical Center researchers.

13 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Chronic sleep loss can cause certain neurotoxic molecules to permeate into brain tissue

The longer the insomnia, junctions of cerebral blood vessels begin to degrade. In search of the answer to why do we sleep, research conducted at the Mexican Metropolitan Autonomous University (UAM) revealed that chronic sleep loss can cause certain neurotoxic molecules, which normally circulate in the blood, to be transported to the central nervous system and interfere with the function of neurons.

10 Jun 2014

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Merck, known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in the company's global Phase 3 clinical trial, ONCEMRK.

6 Jun 2014

Usage of marijuana impairs quality of sleep

A new study suggests that marijuana use is associated with impaired sleep quality.

3 Jun 2014

Study suggests that circadian factors may contribute to suicidality

A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.

3 Jun 2014

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Orexo AB announces a new partnership between Orexo US, Inc. and inVentiv Health for the commercialization of Zubsolv in the US.

20 May 2014

Study: Sleep apnea common among survivors of acute respiratory failure

Clinically important sleep apnea is common among survivors of acute respiratory failure, according to a new study presented at the 2014 American Thoracic Society International Conference.

19 May 2014

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens - the number who have fallen into the "coverage gap" is estimated at 5 million - amazes and frustrates health experts.

6 May 2014

Virtual patient, medical record and questions appear effective in recognizing suicide risk

A virtual patient, the electronic medical record, and questions about how well patients sleep appear effective new tools in recognizing suicide risk, researchers say.

6 May 2014

Free educational event for patients with Graves' disease and thyroid eye disease

The Massachusetts Eye and Ear and the Graves' Disease & Thyroid Foundation will host a free educational event for patients living with Graves' disease and thyroid eye disease on Saturday, May 10 from 8:30 a.m. to noon at Mass. Eye and Ear's Meltzer Auditorium, 3rd floor, 243 Charles Street, Boston, Mass., 02114.

30 Apr 2014

Johns Hopkins research may help manage the disruptive effects experienced by shift workers

Johns Hopkins researchers report that they have identified a protein essential to the formation of the tiny brain region in mice that coordinates sleep-wake cycles and other so-called circadian rhythms.

26 Apr 2014

Pernix completes sale of Pernix Manufacturing to Woodfield Pharmaceutical

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced that it has closed on the sale of its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC ("PML") to Woodfield Pharmaceutical LLC.

25 Apr 2014

Sleeping more than 8 hours favours development of cognitive impairment in people over 65

Sleeping more than 8 hours and less than 6 and the lack of cognitive stimulation such as reading favours the development of cognitive impairment in people over 65. This is the main conclusion of a study carried out by researchers from the Department of Pharmacy at the University CEU Cardenal Herrera and pharmacists in the Valencian Region (Spain).

23 Apr 2014

Insomnia News and Research

Latest Insomnia News and Research

Good news for adults who suffer from insomnia

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Researchers explore shiatsu to help people with chronic pain fall asleep

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

Fighting off illness causes sleep deprivation and affects memory

Proteins causing daytime sleepiness also play crucial role in bone formation

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Chronic sleep loss can cause certain neurotoxic molecules to permeate into brain tissue

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Usage of marijuana impairs quality of sleep

Study suggests that circadian factors may contribute to suicidality

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Study: Sleep apnea common among survivors of acute respiratory failure

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

Virtual patient, medical record and questions appear effective in recognizing suicide risk

Free educational event for patients with Graves' disease and thyroid eye disease

Johns Hopkins research may help manage the disruptive effects experienced by shift workers

Pernix completes sale of Pernix Manufacturing to Woodfield Pharmaceutical

Sleeping more than 8 hours favours development of cognitive impairment in people over 65

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Insomnia News and Research

Latest Insomnia News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in